Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
RZLT is expected to report earnings to fall 25.50% to -14 cents per share on November 05
Q3'26
Est.
$-0.15
Q2'26
Missed
by $0.05
Q1'26
Beat
by $0.02
Q4'25
Missed
by $0.03
Q3'25
Beat
by $0.04
The last earnings report on September 24 showed earnings per share of -20 cents, missing the estimate of -14 cents. With 232.07K shares outstanding, the current market capitalization sits at 402.36M.